Environmentally determined genetic expression: Clinical correlates with molecular variants of carbamyl phosphate synthetase I

Molecular Genetics and Metabolism

Volumn 81, Issue SUPPL., 2004, Pages 12-19

  Summar, Marshall L ^a   Hall, Lynn ^a   Christman, Brian ^b   Barr, Frederick ^b   Smith, Heidi ^b   Kallianpur, Asha ^b   Brown, Nancy ^b   Yadav, Meeta ^a   Willis, Alecia ^a   Eeds, Angela ^a   Cermak, Emma ^a   Summar, Samantha ^a   Wilson, Ann ^a   Arvin, Molly ^a   Putnam, Allison ^a   Wills, Melissa ^a   Cunningham, Gary ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arginine; Bone marrow transplant; Carbamoyl phosphate; Cardiac surgery; Citrulline; Environment; Nitric oxide; Polymorphisms; Pulmonary hypertension; Urea cycle

Indexed keywords

ARGININE; CARBAMOYL PHOSPHATE SYNTHASE; CITRULLINE; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CARBAMYL PHOSPHATE SYNTHETASE DEFICIENCY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; ENZYME DEFICIENCY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEART SURGERY; HUMAN; HYPERAMMONEMIA; INFANT; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; UREA CYCLE;

EID: 12144291030     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.11.014     Document Type: Article

References (22)

1. Jackson M.J., Beaudet A.L., O'Brien W.E. Mammalian urea cycle enzymes. Annu. Rev. Genet. 20:1986;431-464.
2. Rubio V., Ramponi G., Grisolia S. Carbamoyl phosphate synthetase I of human liver. Purification, some properties and immunological cross-reactivity with the rat liver enzyme. Biochim. Biophys. Acta. 659:1981;150-160.
3. Rodriguez-Aparicio L.B., Guadalajara A.M., Rubio V. Physical location of the site for N-acetyl-L-glutamate, the allosteric activator of carbamoyl phosphate synthetase, in the 20-kilodalton COOH-terminal domain. Biochemistry. 28:1989;3070-3074.
4. Britton H.G., Garcia-Espana A., Goya P., Rozas I., Rubio V. A structure-reactivity study of the binding of acetylglutamate to carbamoyl phosphate synthetase I. Eur. J. Biochem. 188:1990;47-53.
5. Lipsitz E.C., Weinstein S., Smerling A.J., Stolar C.J. Endogenous nitric oxide and pulmonary vascular tone in the neonate. J. Pediatr. Surg. 31:1996;137-140.
6. Nelin L.D., Moshin J., Thomas C.J., Sasidharan P., Dawson C.A. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig. Pediatr. Res. 35:1994;20-24.
7. Shaul P.W., Farrar M.A., Zellers T.M. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am. J. Physiol. 262:1992;H355-H364.
8. ′ -monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension J. Pediatr. 130:1997;603-611.
9. Hecker M., Sessa W.C., Harris H.J., Anggard E.E., Vane J.R. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. USA. 87:1990;8612-8616.
10. Naber C.K., Baumgart D., Altmann C., Siffert W., Erbel R., Heusch G. eNOS 894T allele and coronary blood flow at rest and during adenosine- induced hyperemia. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H1908-H1912.
11. Pearson D.L., Dawling S., Walsh W.F., Haines J.L., Christman B.W., Bazyk A., Scott N., Summar M.L. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N. Engl. J. Med. 344:2001;1832-1838.
12. Droma Y., Hanaoka M., Ota M., Katsuyama Y., Koizumi T., Fujimoto K., Kobayashi T., Kubo K. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 106:2002;826-830.
13. Leeson C.P., Hingorani A.D., Mullen M.J., Jeerooburkhan N., Kattenhorn M., Cole T.J., Muller D.P., Lucas A., Humphries S.E., Deanfield J.E. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ. Res. 90:2002;1153-1158.
14. Tanus-Santos J.E., Desai M., Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 11:2001;719-725.
15. Wattanapitayakul S.K., Mihm M.J., Young A.P., Bauer J.A. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol. Sci. 22:2001;361-368.
16. Walsh-Sukys M.C., Tyson J.E., Wright L.L., Bauer C.R., Korones S.B., Stevenson D.K., Verter J., Stoll B.J., Lemons J.A., Papile L.A., Shankaran S., Donovan E.F., Oh W., Ehrenkranz R.A., Fanaroff A.A. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 105:2000;14-20.
17. Clark R.H., Kueser T.J., Walker M.W., Southgate W.M., Huckaby J.L., Perez J.A., Roy B.J., Keszler M., Kinsella J.P. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical inhaled nitric oxide research group. N. Engl. J. Med. 342:2000;469-474.
18. Roberts J.D. Jr., Fineman J.R., Morin 3rd F.C., Shaul P.W., Rimar S., Schreiber M.D., Polin R.A., Zwass M.S., Zayek M.M., Gross I., Heymann M.A., Zapol W.M. Jr. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group. N. Engl. J. Med. 336:1997;605-610.
19. Barr F.E., Beverley H., VanHook K., Cermak E., Christian K., Drinkwater D., Dyer K., Raggio N.T., Moore J.H., Christman B., Summar M. Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J. Pediatr. 142:2003;26-30.
20. Summar M.L., Hall L.D., Eeds A.M., Hutcheson H.B., Kuo A.N., Willis A.S., Rubio V., Arvin M.K., Schofield J.P., Dawson E.P. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene. Gene. 311:2003;51-57.
21. Moore J.H., Williams S.M. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 34:2002;88-95.
22. Summar M.L., Gainer J.V., Pretorius M., Malave H., Christman B.W., Vaughan D.E., Brown N.J. Relationship between carbamoyl-phosphate synthetase genotype and nitric oxide in humans. Hypertension. 42:2003;a72.